25-Hydroxyvitamin D Levels and Albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)

American Journal of Kidney Diseases

Volumn 50, Issue 1, 2007, Pages 69-77

  de Boer, Ian H ^a   Ioannou, George N ^a   Kestenbaum, Bryan ^a   Brunzell, John D ^b   Weiss, Noel S ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Division of Metabolism Endocrinology and Nutrition   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

albuminuria; epidemiology; kidney; microalbuminuria; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN;

ADULT; AGED; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE MARKER; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY; PREVALENCE; PUBLIC HEALTH; SEX DIFFERENCE; SMOKING; STATISTICAL SIGNIFICANCE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ALBUMINURIA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; REFERENCE VALUES; SEASONS; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 34250762524     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.04.015     Document Type: Article

References (50)

1. Hunsicker L.G., Adler S., Caggiula A., et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51 (1997) 1908-1919
2. Ruggenenti P., Perna A., Mosconi L., Pisoni R., and Remuzzi G. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). Kidney Int 53 (1998) 1209-1216
3. Hillege H.L., Fidler V., Diercks G.F., et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106 (2002) 1777-1782
4. Arnlov J., Evans J.C., Meigs J.B., et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: The Framingham Heart Study. Circulation 112 (2005) 969-975
5. Gerstein H.C., Mann J.F., Yi Q., et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286 (2001) 421-426
6. Ibsen H., Olsen M.H., Wachtell K., et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study. Hypertension 45 (2005) 198-202
7. de Zeeuw D., Remuzzi G., Parving H.H., et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110 (2004) 921-927
8. Calvo G., and de Andres-Trelles F. Albuminuria as a surrogate marker for drug development: A European Regulatory perspective. Kidney Int Suppl 92 (2004) S126-S127
9. Dusso A.S., Brown A.J., and Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 289 (2005) F8-F28
10. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., and Cao L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110 (2002) 229-238
11. Li Y.C., Qiao G., Uskokovic M., Xiang W., Zheng W., and Kong J. Vitamin D: A negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 89-90 (2004) 387-392
12. 3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int 53 (1998) 1696-1705
13. 3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Am J Physiol Renal Physiol 286 (2004) F526-F533
14. Resnick L.M., Muller F.B., and Laragh J.H. Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 105 (1986) 649-654
15. Lind L., Hanni A., Lithell H., Hvarfner A., Sorensen O.H., and Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 8 (1995) 894-901
16. Baynes K.C., Boucher B.J., Feskens E.J., and Kromhout D. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 40 (1997) 344-347
17. Ford E.S., Ajani U.A., McGuire L.C., and Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 28 (2005) 1228-1230
18. Scragg R., Sowers M., and Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 27 (2004) 2813-2818
19. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes FaNB, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorous, Magnesium, Vitamin D, and Fluoride (1997), National Academy, Washington, DC
20. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 42 suppl (2003) S1-S201
21. National Center for Health Statistics. Plan and Operations of the Third National Health and Nutrition Examination Survey, 1988-94. Vital Health Stat 1 32 (1994) 94-1308
22. Schmidt-Gayk H., Grawunder C., Tschope W., et al. 25-Hydroxy-vitamin-D in nephrotic syndrome. Lancet 2 (1977) 105-108
23. Grymonprez A., Proesmans W., Van Dyck M., Jans I., Goos G., and Bouillon R. Vitamin D metabolites in childhood nephrotic syndrome. Pediatr Nephrol 9 (1995) 278-281
24. Saha H. Calcium and vitamin D homeostasis in patients with heavy proteinuria. Clin Nephrol 41 (1994) 290-296
25. Gunter E., Lewis B., and Koncikowski S. Laboratory Methods Used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994 (CD-ROM) (1996), Centers for Disease Control and Prevention, Hyattsville, MD
26. Hollis B.W. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135 (2005) 317-322
27. Dawson-Hughes B., Heaney R.P., Holick M.F., Lips P., Meunier P.J., and Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 16 (2005) 713-716
28. Jones C.A., Francis M.E., Eberhardt M.S., et al. Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 39 (2002) 445-459
29. Warram J.H., Gearin G., Laffel L., and Krolewski A.S. Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 7 (1996) 930-937
30. Mattix H.J., Hsu C.Y., Shaykevich S., and Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria: Implications of sex and race. J Am Soc Nephrol 13 (2002) 1034-1039
31. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 suppl (2002) S1-S266
32. Levey A.S., Greene T., Kusek J.W., and Beck G.J. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) 0828A (abstr)
33. Coresh J., Astor B.C., McQuillan G., et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 39 (2002) 920-929
34. Levey A.S., Eckardt K.U., Tsukamoto Y., et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67 (2005) 2089-2100
35. McNutt L.A., Wu C., Xue X., and Hafner J.P. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157 (2003) 940-943
36. Looker A.C., Dawson-Hughes B., Calvo M.S., Gunter E.W., and Sahyoun N.R. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30 (2002) 771-777
37. Verrotti A., Basciani F., Carle F., Morgese G., and Chiarelli F. Calcium metabolism in adolescents and young adults with type 1 diabetes mellitus without and with persistent microalbuminuria. J Endocrinol Invest 22 (1999) 198-202
38. 3 and osteocalcin in patients with early diabetic nephropathy. Diabetes Res Clin Pract 38 (1997) 53-59
39. Kano K., Nonoda A., Yoneshima H., and Suda T. Serum concentrations of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D in patients with various types of renal disease. Clin Nephrol 14 (1980) 274-279
40. Durvasula R.V., and Shankland S.J. The renin-angiotensin system in glomerular podocytes: Mediator of glomerulosclerosis and link to hypertensive nephropathy. Curr Hypertens Rep 8 (2006) 132-138
41. Kadowaki S., and Norman A.W. Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas. J Clin Invest 73 (1984) 759-766
42. 3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 119 (1986) 84-90
43. Chiu K.C., Chu A., Go V.L., and Saad M.F. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 79 (2004) 820-825
44. Mykkanen L., Zaccaro D.J., Wagenknecht L.E., Robbins D.C., Gabriel M., and Haffner S.M. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: The Insulin Resistance Atherosclerosis Study. Diabetes 47 (1998) 793-800
45. Masuda S., and Jones G. Promise of vitamin D analogues in the treatment of hyperproliferative conditions. Mol Cancer Ther 5 (2006) 797-808
46. Agarwal R., Acharya M., Tian J., et al. Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int 68 (2005) 2823-2828
47. Christensen E.I., and Birn H. Megalin and cubilin: Synergistic endocytic receptors in renal proximal tubule. Am J Physiol Renal Physiol 280 (2001) F562-F573
48. Sato K.A., Gray R.W., and Lemann Jr. J. Urinary excretion of 25-hydroxyvitamin D in health and the nephrotic syndrome. J Lab Clin Med 99 (1982) 325-330
49. Coresh J., Astor B.C., Greene T., Eknoyan G., and Levey A.S. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41 (2003) 1-12
50. Mokdad A.H., Ford E.S., Bowman B.A., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 (2003) 76-79